{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:58:10Z","timestamp":1789588690798,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA198999"],"award-info":[{"award-number":["CA198999"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Activated hepatic stellate cell (aHSC)-mediated liver fibrosis is essential to the development of liver metastasis. Here, we discover intra-hepatic scale-up of relaxin (RLN, an anti-fibrotic peptide) in response to fibrosis along with the upregulation of its primary receptor (RXFP1) on aHSCs. The elevated expression of RLN serves as a natural regulator to deactivate aHSCs and resolve liver fibrosis. Therefore, we hypothesize this endogenous liver fibrosis repair mechanism can be leveraged for liver metastasis treatment via enforced RLN expression. To validate the therapeutic potential, we utilize aminoethyl anisamide-conjugated lipid-calcium-phosphate nanoparticles to deliver plasmid DNA encoding RLN. The nanoparticles preferentially target metastatic tumor cells and aHSCs within the metastatic lesion and convert them as an in situ RLN depot. Expressed RLN reverses the stromal microenvironment, which makes it unfavorable for established liver metastasis to grow. In colorectal, pancreatic, and breast cancer liver metastasis models, we confirm the RLN gene therapy results in significant inhibition of metastatic progression and prolongs survival. In addition, enforced RLN expression reactivates intra-metastasis immune milieu. The combination of the RLN gene therapy with PD-L1 blockade immunotherapy further produces a synergistic anti-metastatic efficacy. Collectively, the targeted RLN gene therapy represents a highly efficient, safe, and versatile anti-metastatic modality, and is promising for clinical translation.<\/jats:p>","DOI":"10.1038\/s41467-019-10893-8","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T06:03:06Z","timestamp":1562306586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0358-6014","authenticated-orcid":false,"given":"Mengying","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leaf","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"10893_CR1","doi-asserted-by":"publisher","first-page":"1805760","DOI":"10.1002\/adfm.201805760","volume":"29","author":"M Hu","year":"2018","unstructured":"Hu, M. & Huang, L. Nanomaterial manipulation of immune microenvironment in the diseased liver. Adv. Funct. Mater. 29, 1805760 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"10893_CR2","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3892\/or.2017.5531","volume":"37","author":"A Bandar","year":"2017","unstructured":"Bandar, A., Hussain, M. & Kim, N. K. Current status and future perspectives on treatment of liver metastasis in colorectal cancer. Oncol. Rep. 37, 2553\u20132564 (2017).","journal-title":"Oncol. Rep."},{"key":"10893_CR3","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.ejrad.2016.08.014","volume":"85","author":"SJ Ahn","year":"2016","unstructured":"Ahn, S. J., Kim, J. H., Park, S. J. & Han, J. K. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur. J. Radiol. 85, 1867\u20131874 (2016).","journal-title":"Eur. J. Radiol."},{"key":"10893_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1470-2045(15)00411-8","volume":"17","author":"T Takashima","year":"2016","unstructured":"Takashima, T. et al. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 17, 90\u201398 (2016).","journal-title":"Lancet Oncol."},{"key":"10893_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke, I. et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823 (2013).","journal-title":"Nat. Commun."},{"key":"10893_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","volume":"354","author":"T-h Hu","year":"2014","unstructured":"Hu, T.-h et al. SDF-1\/CXCR4 promotes epithelial\u2013mesenchymal transition and progression of colorectal cancer by activation of the Wnt\/\u03b2-catenin signaling pathway. Cancer Lett. 354, 417\u2013426 (2014).","journal-title":"Cancer Lett."},{"key":"10893_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.24384","volume":"54","author":"N Kang","year":"2011","unstructured":"Kang, N., Gores, G. J. & Shah, V. H. Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54, 707\u2013713 (2011).","journal-title":"Hepatology"},{"key":"10893_CR8","doi-asserted-by":"publisher","first-page":"e0153118","DOI":"10.1371\/journal.pone.0153118","volume":"11","author":"S Robert","year":"2016","unstructured":"Robert, S., Gicquel, T., Bodin, A., Lagente, V. & Boichot, E. Characterization of the MMP\/TIMP imbalance and collagen production induced by IL-1\u03b2 or TNF-\u03b1 release from human hepatic stellate cells. PLoS ONE 11, e0153118 (2016).","journal-title":"PLoS ONE"},{"key":"10893_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev-cellbio-100617-062855","volume":"34","author":"MH Sherman","year":"2018","unstructured":"Sherman, M. H. Stellate cells in tissue repair, inflammation, and cancer. Annu. Rev. Cell Dev. Biol. 34, 333\u2013355 (2018).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10893_CR10","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.4161\/cc.9.24.14322","volume":"9","author":"H-W Wang","year":"2010","unstructured":"Wang, H.-W. & Joyce, J. A. Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle 9, 4824\u20134835 (2010).","journal-title":"Cell Cycle"},{"key":"10893_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"10893_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3902","volume":"15","author":"SJ Turley","year":"2015","unstructured":"Turley, S. J., Cremasco, V. & Astarita, J. L. Immunological hallmarks of stromal cells in the tumour microenvironment. Nat. Rev. Immunol. 15, 669 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"10893_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1158\/2326-6066.CIR-16-0325","volume":"5","author":"PC Tumeh","year":"2017","unstructured":"Tumeh, P. C. et al. Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol. Res. 5, 417\u2013424 (2017).","journal-title":"Cancer Immunol. Res."},{"key":"10893_CR14","doi-asserted-by":"publisher","first-page":"e0192227","DOI":"10.1371\/journal.pone.0192227","volume":"13","author":"M Tamiya","year":"2018","unstructured":"Tamiya, M. et al. Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: a retrospective multicenter trial. PLoS ONE 13, e0192227 (2018).","journal-title":"PLoS ONE"},{"key":"10893_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro, A., Ramachandran, P., Iredale, J. P. & Fallowfield, J. A. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat. Rev. Immunol. 14, 181 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"10893_CR16","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/hep.26627","volume":"59","author":"JA Fallowfield","year":"2014","unstructured":"Fallowfield, J. A. et al. Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo. Hepatology 59, 1492\u20131504 (2014).","journal-title":"Hepatology"},{"key":"10893_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/bph.13529","volume":"174","author":"C Samuel","year":"2017","unstructured":"Samuel, C. et al. Anti\u2010fibrotic actions of relaxin. Br. J. Pharmacol. 174, 962\u2013976 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"10893_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/1755-5922.12231","volume":"35","author":"RK Ghosh","year":"2017","unstructured":"Ghosh, R. K. et al. Serelaxin in acute heart failure: most recent update on clinical and preclinical evidence. Cardiovasc. Ther. 35, 55\u201363 (2017).","journal-title":"Cardiovasc. Ther."},{"key":"10893_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2018.09.031","volume":"290","author":"DF Mardhian","year":"2018","unstructured":"Mardhian, D. F., Storm, G., Bansal, R. & Prakash, J. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo. J. Control. Release 290, 1\u201310 (2018).","journal-title":"J. Control. Release"},{"key":"10893_CR20","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/bph.13778","volume":"174","author":"R Summers","year":"2017","unstructured":"Summers, R. Recent progress in the understanding of relaxin family peptides and their receptors. Br. J. Pharmacol. 174, 915\u2013920 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"10893_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jconrel.2016.11.022","volume":"243","author":"TJ Goodwin","year":"2016","unstructured":"Goodwin, T. J. & Huang, L. On the article \u201cFindings questioning the involvement of Sigma-1 receptor in the uptake of anisamide-decorated particles\u201d [J. Control. Release 224 (2016) 229-238]: Letter to the Editor 1 (September 14, 2016). J. Control. Release 243, 382 (2016).","journal-title":"J. Control. Release"},{"key":"10893_CR22","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1053\/j.gastro.2007.02.033","volume":"132","author":"S De Minicis","year":"2007","unstructured":"De Minicis, S. et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937\u20131946 (2007).","journal-title":"Gastroenterology"},{"key":"10893_CR23","doi-asserted-by":"publisher","first-page":"16289","DOI":"10.1074\/jbc.M600711200","volume":"281","author":"W Boers","year":"2006","unstructured":"Boers, W. et al. Transcriptional profiling reveals novel markers of liver fibrogenesis gremlin and insulin-like growth factor-binding proteins. J. Biol. Chem. 281, 16289\u201316295 (2006).","journal-title":"J. Biol. Chem."},{"key":"10893_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s10585-013-9591-8","volume":"30","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., Davis, C., Ryan, J., Janney, C. & Pe\u00f1a, M. M. O. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin. Exp. Metastas-. 30, 903\u2013918 (2013).","journal-title":"Clin. Exp. Metastas-."},{"key":"10893_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125\u2013172 (2008).","journal-title":"Physiol. Rev."},{"key":"10893_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fphar.2017.00318","volume":"8","author":"BL McVicker","year":"2017","unstructured":"McVicker, B. L. & Bennett, R. G. Novel anti-fibrotic therapies. Front. Pharmacol. 8, 318 (2017).","journal-title":"Front. Pharmacol."},{"key":"10893_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2009.03836.x","volume":"1160","author":"S Kietz","year":"2009","unstructured":"Kietz, S., Feng, S., Agoulnik, A. & Hombach\u2010Klonisch, S. Estrogen and TCDD influence RLN2 gene activity in estrogen receptor\u2010positive human breast cancer cells. Ann. N.Y. Acad. Sci. 1160, 367\u2013373 (2009).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10893_CR28","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/pros.20423","volume":"66","author":"VC Thompson","year":"2006","unstructured":"Thompson, V. C. et al. Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens. Prostate 66, 1698\u20131709 (2006).","journal-title":"Prostate"},{"key":"10893_CR29","doi-asserted-by":"publisher","first-page":"55368","DOI":"10.18632\/oncotarget.10552","volume":"7","author":"J de Ridder","year":"2016","unstructured":"de Ridder, J. et al. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget 7, 55368 (2016).","journal-title":"Oncotarget"},{"key":"10893_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.biomaterials.2017.07.007","volume":"141","author":"TJ Goodwin","year":"2017","unstructured":"Goodwin, T. J. et al. Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival. Biomaterials 141, 260\u2013271 (2017).","journal-title":"Biomaterials"},{"key":"10893_CR31","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.biomaterials.2013.12.022","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu, Y., Hu, Y. & Huang, L. Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles. Biomaterials 35, 3027\u20133034 (2014).","journal-title":"Biomaterials"},{"key":"10893_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","volume":"31","author":"T-P Su","year":"2010","unstructured":"Su, T.-P., Hayashi, T., Maurice, T., Buch, S. & Ruoho, A. E. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 31, 557\u2013566 (2010).","journal-title":"Trends Pharmacol. Sci."},{"key":"10893_CR33","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.bbamcr.2014.01.012","volume":"1843","author":"W-A Wang","year":"2014","unstructured":"Wang, W.-A., Groenendyk, J. & Michalak, M. Endoplasmic reticulum stress associated responses in cancer. Biochim. et. Biophys. Acta (BBA)-Mol. Cell Res. 1843, 2143\u20132149 (2014).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10893_CR34","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1043-2760(02)00664-1","volume":"13","author":"R Ivell","year":"2002","unstructured":"Ivell, R. & Einspanier, A. Relaxin peptides are new global players. Trends Endocrinol. Metabolism 13, 343\u2013348 (2002).","journal-title":"Trends Endocrinol. Metabolism"},{"key":"10893_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2009.03.007","volume":"154","author":"RG Bennett","year":"2009","unstructured":"Bennett, R. G. Relaxin and its role in the development and treatment of fibrosis. Transl. Res. 154, 1\u20136 (2009).","journal-title":"Transl. Res."},{"key":"10893_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-1046-1","volume":"16","author":"G Weiss","year":"2016","unstructured":"Weiss, G. et al. Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour. BMC Pregnancy Childbirth 16, 260 (2016).","journal-title":"BMC Pregnancy Childbirth"},{"key":"10893_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.tips.2016.02.007","volume":"37","author":"CS Samuel","year":"2016","unstructured":"Samuel, C. S., Summers, R. J. & Hewitson, T. D. Antifibrotic actions of serelaxin\u2014new roles for an old player. Trends Pharmacol. Sci. 37, 485\u2013497 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"10893_CR38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jconrel.2015.08.017","volume":"219","author":"L Miao","year":"2015","unstructured":"Miao, L., Lin, C. M. & Huang, L. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. J. Control. Release 219, 192\u2013204 (2015).","journal-title":"J. Control. Release"},{"key":"10893_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink, J. R. et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29\u201339 (2013).","journal-title":"Lancet"},{"key":"10893_CR40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1023\/A:1018901009062","volume":"10","author":"SA Chen","year":"1993","unstructured":"Chen, S. A. et al. The pharmacokinetics of recombinant human relaxin in nonpregnant women after intravenous, intravaginal, and intracervical administration. Pharm. Res. 10, 834\u2013838 (1993).","journal-title":"Pharm. Res."},{"key":"10893_CR41","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1038\/cti.2017.47","volume":"6","author":"CL Elsegood","year":"2017","unstructured":"Elsegood, C. L., Tirnitz\u2010Parker, J. E., Olynyk, J. K. & Yeoh, G. C. Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinoma. Clin. Transl. Immunol. 6, e161 (2017).","journal-title":"Clin. Transl. Immunol."},{"key":"10893_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00011-010-0233-1","volume":"60","author":"J Chen","year":"2011","unstructured":"Chen, J. et al. Intrahepatic levels of PD-1\/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm. Res. 60, 47\u201353 (2011).","journal-title":"Inflamm. Res."},{"key":"10893_CR43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.20488","volume":"40","author":"MC Yu","year":"2004","unstructured":"Yu, M. C. et al. Inhibition of T\u2010cell responses by hepatic stellate cells via B7\u2010H1\u2013mediated T\u2010cell apoptosis in mice. Hepatology 40, 1312\u20131321 (2004).","journal-title":"Hepatology"},{"key":"10893_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04605-x","volume":"9","author":"W Song","year":"2018","unstructured":"Song, W. et al. Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap. Nat. Commun. 9, 2237 (2018).","journal-title":"Nat. Commun."},{"key":"10893_CR45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","volume":"1832","author":"LA Borthwick","year":"2013","unstructured":"Borthwick, L. A., Wynn, T. A. & Fisher, A. J. Cytokine mediated tissue fibrosis. Biochim. et. Biophys. Acta (BBA)-Mol. Basis Dis. 1832, 1049\u20131060 (2013).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10893_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe, I. N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3, 51 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"10893_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12032-010-9515-2","volume":"28","author":"C-Y Mu","year":"2011","unstructured":"Mu, C.-Y., Huang, J.-A., Chen, Y., Chen, C. & Zhang, X.-G. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med. Oncol. 28, 682\u2013688 (2011).","journal-title":"Med. Oncol."},{"key":"10893_CR48","first-page":"709","volume":"73","author":"D Bani","year":"1995","unstructured":"Bani, D., Bigazzi, M., Masini, E., Bani, G. & Sacchi, T. B. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab. Investig. 73, 709\u2013716 (1995).","journal-title":"Lab. Investig."},{"key":"10893_CR49","doi-asserted-by":"crossref","unstructured":"Erikson, M. S. & Unemori, E. N. in Relaxin 2000 373\u2212381 (Springer, New York, 2001).","DOI":"10.1007\/978-94-017-2877-5_62"},{"key":"10893_CR50","doi-asserted-by":"crossref","unstructured":"Amitrano, L., Guardascione, M. A., Brancaccio, V. & Balzano, A. in Seminars in Liver Disease. Vol. 22 (eds Berk, P. D. & Okuda, K.) 83\u221296 (Thieme Medical Publishers, Inc., New York, 2002).","DOI":"10.1055\/s-2002-23205"},{"key":"10893_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2015.03.003","volume":"165","author":"J-H Park","year":"2015","unstructured":"Park, J.-H., Jeong, S.-Y., Choi, A.-J. & Kim, S.-J. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-\u03baB1. Immunol. Lett. 165, 10\u201319 (2015).","journal-title":"Immunol. Lett."},{"key":"10893_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1189\/jlb.0110057","volume":"88","author":"E Davila","year":"2010","unstructured":"Davila, E. & Kolls, J. A \u201cToll\u201d for Th17 cell expansion. J. Leukoc. Biol. 88, 5\u20137 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"10893_CR53","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jss.2009.02.023","volume":"164","author":"C Yam","year":"2010","unstructured":"Yam, C. et al. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J. Surg. Res. 164, 248\u2013255 (2010).","journal-title":"J. Surg. Res."},{"key":"10893_CR54","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ncb3340","volume":"18","author":"SR Nielsen","year":"2016","unstructured":"Nielsen, S. R. et al. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nat. Cell Biol. 18, 549 (2016).","journal-title":"Nat. Cell Biol."},{"key":"10893_CR55","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816 (2015).","journal-title":"Nat. Cell Biol."},{"key":"10893_CR56","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","volume":"21","author":"CJ Whatcott","year":"2015","unstructured":"Whatcott, C. J. et al. Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clin. Cancer Res. 21, 3561\u20133568 (2015).","journal-title":"Clin. Cancer Res."},{"key":"10893_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00441-014-2075-6","volume":"359","author":"I Gonzalez-Zubeldia","year":"2015","unstructured":"Gonzalez-Zubeldia, I. et al. Co-migration of colon cancer cells and CAFs induced by TGF\u03b2 1 enhances liver metastasis. Cell Tissue Res. 359, 829\u2013839 (2015).","journal-title":"Cell Tissue Res."},{"key":"10893_CR58","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1038\/ncomms7879","volume":"6","author":"P Bu","year":"2015","unstructured":"Bu, P. et al. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-\u03b2. Nat. Commun. 6, 6879 (2015).","journal-title":"Nat. Commun."},{"key":"10893_CR59","doi-asserted-by":"publisher","first-page":"364ra153","DOI":"10.1126\/scitranslmed.aag2306","volume":"8","author":"TJ Goodwin","year":"2016","unstructured":"Goodwin, T. J., Zhou, Y., Musetti, S. N., Liu, R. & Huang, L. Local and transient gene expression primes the liver to resist cancer metastasis. Sci. Transl. Med. 8, 364ra153\u2013364ra153 (2016).","journal-title":"Sci. Transl. Med."},{"key":"10893_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97 (2013).","journal-title":"Nature"},{"key":"10893_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.7150\/ijms.6283","volume":"11","author":"F Dehghan","year":"2014","unstructured":"Dehghan, F., Muniandy, S., Yusof, A. & Salleh, N. Sex-steroid regulation of relaxin receptor isoforms (RXFP1 & RXFP2) expression in the patellar tendon and lateral collateral ligament of female WKY rats. Int. J. Med. Sci. 11, 180 (2014).","journal-title":"Int. J. Med. Sci."},{"key":"10893_CR62","doi-asserted-by":"publisher","first-page":"1802847","DOI":"10.1002\/adfm.201802847","volume":"28","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Nanoparticle\u2010mediated HMGA1 silencing promotes lymphocyte infiltration and boosts checkpoint blockade immunotherapy for cancer. Adv. Funct. Mater. 28, 1802847 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"10893_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000085342","volume":"22","author":"M Heijstek","year":"2005","unstructured":"Heijstek, M., Kranenburg, O. & Rinkes, I. B. Mouse models of colorectal cancer and liver metastases. Dig. Surg. 22, 16\u201325 (2005).","journal-title":"Dig. Surg."},{"key":"10893_CR64","first-page":"3321","volume":"34","author":"WY Lee","year":"2014","unstructured":"Lee, W. Y., Hong, H. K., Ham, S. K., Kim, C. I. & Cho, Y. B. Comparison of colorectal cancer in differentially established liver metastasis models. Anticancer Res. 34, 3321\u20133328 (2014).","journal-title":"Anticancer Res."},{"key":"10893_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.21288","volume":"118","author":"JD Silvertown","year":"2006","unstructured":"Silvertown, J. D., Ng, J., Sato, T., Summerlee, A. J. & Medin, J. A. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int. J. Cancer 118, 62\u201373 (2006).","journal-title":"Int. J. Cancer"},{"key":"10893_CR66","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1096\/fj.06-6847com","volume":"21","author":"JD Silvertown","year":"2007","unstructured":"Silvertown, J. D. et al. Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth. FASEB J. 21, 754\u2013765 (2007).","journal-title":"FASEB J."},{"key":"10893_CR67","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ijc.20452","volume":"112","author":"R Banerjee","year":"2004","unstructured":"Banerjee, R., Tyagi, P., Li, S. & Huang, L. Anisamide\u2010targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int. J. Cancer 112, 693\u2013700 (2004).","journal-title":"Int. J. Cancer"},{"key":"10893_CR68","doi-asserted-by":"publisher","first-page":"8690","DOI":"10.1021\/acsnano.7b01786","volume":"11","author":"L Miao","year":"2017","unstructured":"Miao, L. et al. Transient and local expression of chemokine and immune checkpoint traps to treat pancreatic cancer. ACS Nano 11, 8690\u20138706 (2017).","journal-title":"ACS Nano"},{"key":"10893_CR69","doi-asserted-by":"crossref","unstructured":"Constandinou, C., Henderson, N. & Iredale, J. P. in Fibrosis Research (eds Varga J., Brenner D. A.\u00a0& Phan S. H.) 237\u2212250 (Springer, New York, 2005).","DOI":"10.1385\/1-59259-940-0:237"},{"key":"10893_CR70","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.aaa0672","volume":"347","author":"RJ Perry","year":"2015","unstructured":"Perry, R. J., Zhang, D., Zhang, X.-M., Boyer, J. L. & Shulman, G. I. Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347, 1253\u20131256 (2015).","journal-title":"Science"},{"key":"10893_CR71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","volume":"158","author":"J Li","year":"2012","unstructured":"Li, J., Yang, Y. & Huang, L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J. Control. Release 158, 108\u2013114 (2012).","journal-title":"J. Control. Release"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10893-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10893-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:12:09Z","timestamp":1671217929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10893-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10893"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10893-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736141936.793567132","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"13 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2993"}}